Standout Papers

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: ... 2007 2026 2013 2019 548
  1. Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System (2007)
    Clifford A. Hudis, William E. Barlow et al. Journal of Clinical Oncology
  2. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials (2008)
    Edward L. Korn, Sandra J. Lee et al. Journal of Clinical Oncology

Immediate Impact

11 by Nobel laureates 26 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
2020 Standout
1 intermediate paper

Works of J. W. Chapman being referenced

Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
2017
Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
2008 Standout

Author Peers

Author Last Decade Papers Cites
J. W. Chapman 904 464 174 449 15 1.4k
Alan Barge 810 163 126 404 21 1.5k
Reena Philip 552 273 63 386 23 1.0k
Elena Fountzilas 600 503 189 861 48 1.7k
Yoke-Eng Chiew 554 498 133 773 9 1.5k
J. Wayne Cowens 839 856 277 453 31 1.6k
Ernesto Wasserman 799 372 68 409 35 1.2k
SA Roberts 366 369 187 429 18 1.1k
Pamela Klein 760 242 146 461 27 1.2k
Fiona M. Blows 600 443 114 550 19 1.3k
Cynthia Osborne 991 418 227 430 12 1.5k

All Works

Loading papers...

Rankless by CCL
2026